PGNY Progyny, Inc. Stock Quote

PGNY [NASD]

Healthcare | Health Information Services | USA

Index	-	P/E	53.57	EPS (ttm)	0.56	Insider Own	1.10%	Shs Outstand	91.41M	Perf Week	11.35%
Market Cap	2.62B	Forward P/E	69.14	EPS next Y	0.43	Insider Trans	-55.05%	Shs Float	77.85M	Perf Month	-11.99%
Income	55.60M	PEG	2.54	EPS next Q	0.04	Inst Own	97.80%	Short Float	7.42%	Perf Quarter	-41.19%
Sales	550.70M	P/S	4.76	EPS this Y	39.70%	Inst Trans	4.66%	Short Ratio	7.85	Perf Half Y	-42.96%
Book/sh	3.06	P/B	9.72	EPS next Y	173.89%	ROA	15.60%	Target Price	59.00	Perf Year	-51.99%
Cash/sh	1.20	P/C	24.82	EPS next 5Y	21.10%	ROE	23.20%	52W Range	25.67 - 68.32	Perf YTD	-40.95%
Dividend	-	P/FCF	226.20	EPS past 5Y	-	ROI	26.10%	52W High	-56.48%	Beta	-
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	86.60%	Gross Margin	21.10%	52W Low	15.82%	ATR	1.79
Employees	311	Current Ratio	2.40	Sales Q/Q	41.00%	Oper. Margin	3.70%	RSI (14)	46.67	Volatility	6.01% 6.02%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-67.20%	Profit Margin	10.10%	Rel Volume	0.69	Prev Close	30.66
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	0.00%	Avg Volume	736.33K	Price	29.73
Recom	1.50	SMA20	1.86%	SMA50	-13.21%	SMA200	-35.81%	Volume	505,815	Change	-3.03%

Dec-02-21

Initiated

Jefferies

Buy

$60

Nov-22-21

Downgrade

Citigroup

Buy → Neutral

$60 → $64

Sep-30-21

Initiated

Berenberg

Buy

$81

Aug-12-21

Initiated

Barclays

Overweight

$64

Jun-02-21

Downgrade

Guggenheim

Buy → Neutral

Apr-29-21

Resumed

JP Morgan

Overweight

$65

Mar-10-21

Upgrade

BofA Securities

Neutral → Buy

$53

Jul-01-20

Initiated

SVB Leerink

Outperform

$35

Jun-02-20

Initiated

Guggenheim

Buy

$30

Nov-19-19

Initiated

SVB Leerink

Outperform

$28

Nov-19-19

Initiated

Piper Jaffray

Overweight

$33

Nov-19-19

Initiated

JP Morgan

Overweight

$26

Nov-19-19

Initiated

Goldman

Buy

$33

Nov-19-19

Initiated

Citigroup

Buy

$30

Jun-24-22 06:00AM	CoDiagnostics, Inc. (CODX) Surges 5.6%: Is This an Indication of Further Gains? Zacks
Jun-22-22 09:39AM	Will Mednax's (MD) New Name Pediatrix Medical be Beneficial? Zacks
Jun-21-22 01:45PM	HCA Healthcare (HCA) Scraps Utah Buyout Post FTC's Roadblock Zacks
Jun-20-22 01:33PM	Centene (CNC) Raises 2022 Guidance, Ups Share Buyback Fund Zacks
Jun-17-22 08:41AM	Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements Zacks
Jun-16-22 04:07PM	Encompass Health (EHC) Forms JV With NCH Healthcare in Naples Zacks
Jun-15-22 02:58PM	Encompass Health (EHC) Plans to Distribute Enhabit Shares Zacks
Jun-14-22 10:13AM	HCA Healthcare's (HCA) Galen College Adds 8th New Facility Zacks
Jun-12-22 09:02AM	Declining Stock and Solid Fundamentals: Is The Market Wrong About Progyny, Inc. (NASDAQ:PGNY)? Simply Wall St.
Jun-10-22 11:40AM	AMN or PGNY: Which Is the Better Value Stock Right Now? Zacks
Jun-07-22 03:20PM	HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks Zacks
09:11AM	Implied Volatility Surging for Progyny (PGNY) Stock Options Zacks
02:10AM	Is it Wise to Invest in Progyny (PGNY)? Insider Monkey
Jun-01-22 03:00PM	Progyny, Inc. to Present at the Jefferies 2022 Healthcare Conference GlobeNewswire -6.45%
May-25-22 11:40AM	AMN vs. PGNY: Which Stock Is the Better Value Option? Zacks
May-24-22 09:00AM	Progyny Lands Employer Benefits Expert in Expansion of Leadership Team GlobeNewswire -5.94%
May-23-22 11:23AM	Baron Funds: We See Potential for Progyny (PGNY) to Grow its Top Line CAGR at Approximately 35% Insider Monkey
May-06-22 12:06PM	The Broken Brown Egg and Progyny Launch the Awareness, Hope, and Activism Grant to Help BIPOC Individuals and Couples Expand their Families GlobeNewswire
May-05-22 06:25PM	Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates Zacks -8.27%
04:05PM	Progyny, Inc. Announces First Quarter 2022 Results GlobeNewswire
Apr-28-22 05:00PM	Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference GlobeNewswire
03:02PM	Analysts Estimate Progyny (PGNY) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-21-22 03:25PM	Progyny, Inc. Announces Details for Its First Quarter 2022 Results Report GlobeNewswire
09:21AM	Investor Optimism Abounds Progyny, Inc. (NASDAQ:PGNY) But Growth Is Lacking Simply Wall St.
Apr-19-22 09:00AM	Progyny and RESOLVE to Launch National Infertility Awareness Week® by Ringing the Nasdaq Stock Market Opening Bell and Lighting the Empire State Building GlobeNewswire
Apr-18-22 09:00AM	Meritage Homes Names Malissia Clinton Its Executive Vice President, General Counsel and Secretary GlobeNewswire
Apr-16-22 12:06PM	Buy Progyny Stock. The Small-Cap Could Be a Big Winner By Tackling Infertility. Barrons.com
Apr-11-22 11:40AM	AVTR vs. PGNY: Which Stock Is the Better Value Option? Zacks
Apr-06-22 09:53AM	Is Progyny (PGNY) a Wise Investment Choice? Insider Monkey
Apr-05-22 10:45AM	2 No-Brainer Stocks to Buy Right Now for Less than $55 Motley Fool
Mar-16-22 11:04AM	Investors in Progyny (NASDAQ:PGNY) have unfortunately lost 13% over the last year Simply Wall St. +8.72%
Mar-15-22 11:40AM	OCDX vs. PGNY: Which Stock Should Value Investors Buy Now? Zacks
Mar-10-22 09:30AM	Progyny, Inc. to Present at the Barclays Global Healthcare Conference GlobeNewswire
Mar-03-22 05:48PM	Progyny expanding headquarters at 1359 Broadway American City Business Journals
Feb-28-22 06:35PM	Progyny (PGNY) Surpasses Q4 Earnings Estimates Zacks
04:05PM	Progyny, Inc. Announces Fourth Quarter and Full Year 2021 Results GlobeNewswire
Feb-21-22 03:01PM	Earnings Preview: Progyny (PGNY) Q4 Earnings Expected to Decline Zacks
Feb-11-22 12:30PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2021 Results Report GlobeNewswire
Jan-26-22 01:38PM	Cim, Llc Buys Berkshire Hathaway Inc, ASML Holding NV, Cactus Inc, Sells Intuitive Surgical ... GuruFocus.com
Jan-14-22 09:38PM	Riverbridge Partners Llc Buys Amedisys Inc, Privia Health Group Inc, Progyny Inc, Sells Gentex ... GuruFocus.com
Jan-05-22 12:00PM	Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-29-21 05:49PM	Progyny Inc Insiders are Selling. Investors Should Take Notice GuruFocus.com
Dec-27-21 09:38PM	DeltaShares(R) S&P 400 Managed Risk ETF Buys GameStop Corp, Tandem Diabetes Care Inc, GXO ... GuruFocus.com
Dec-19-21 06:38AM	Voya VARIABLE PRODUCTS TRUST Buys Avalara Inc, Bio-Techne Corp, Roku Inc, Sells Spotify ... GuruFocus.com
Dec-16-21 03:38AM	SFT Delaware Ivy Small Cap Growth Fund Buys Red Rock Resorts Inc, Herc Holdings Inc, BTRS ... GuruFocus.com
Dec-14-21 06:29PM	Is Progyny, Inc. (PGNY) A Good Stock To Buy? Insider Monkey
Dec-13-21 06:38PM	ON S&P MidCap 400 Index Portfolio Buys GameStop Corp, GXO Logistics Inc, Tandem Diabetes ... GuruFocus.com
Dec-11-21 06:38AM	SPDR S&P MidCap 400 ETF Trust Buys GameStop Corp, GXO Logistics Inc, Tandem Diabetes Care ... GuruFocus.com
05:38AM	Prudential Jennison Small Co Fund, Inc. Buys Ryan Specialty Group Holdings Inc, Bridge ... GuruFocus.com
Dec-08-21 06:38PM	Inv Corp Mid Cap Equity Index Buys GameStop Corp, GXO Logistics Inc, Tandem Diabetes Care Inc, ... GuruFocus.com
Dec-07-21 04:38PM	Mutual of America VIP Mid Cap Index Portfolio (S&P 400) Buys GameStop Corp, GXO Logistics ... GuruFocus.com
Nov-29-21 03:04PM	10 Best Growth Stocks for 2022 Insider Monkey
Nov-10-21 11:38AM	EVP And General Counsel Of Progyny Trades $2.1M In Company Stock Benzinga
Nov-08-21 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's What You Should Know Zacks +6.03%
09:15AM	Progyny (PGNY) Soars to 52-Week High, Time to Cash Out? Zacks
Nov-05-21 12:02AM	Progyny Inc (PGNY) Q3 2021 Earnings Call Transcript Motley Fool
Nov-04-21 06:55PM	Progyny (PGNY) Q3 Earnings Beat Estimates Zacks
05:41PM	Dow Jones Futures: Market Rally Mixed, Nvidia Spikes On Metaverse Push; Four Stocks Flashing Buy Signals Late Investor's Business Daily
04:05PM	Progyny, Inc. Announces Third Quarter 2021 Results GlobeNewswire
Nov-02-21 01:46PM	Should You Think About Buying Progyny, Inc. (NASDAQ:PGNY) Now? Simply Wall St.
Oct-28-21 03:05PM	Progyny (PGNY) Earnings Expected to Grow: Should You Buy? Zacks
Oct-25-21 11:32AM	Fertility Leader Progyny Aims To Deliver 176% Growth This Year Investor's Business Daily
Oct-21-21 03:30PM	Progyny, Inc. Announces Details for Its Third Quarter 2021 Results Report GlobeNewswire
Oct-12-21 11:37AM	Hedge Funds Are Crazy About Progyny, Inc. (PGNY) Insider Monkey
Oct-06-21 11:44AM	Chief Executive Officer Of Progyny Trades $8.8M In Company Stock Benzinga
Oct-05-21 07:21AM	3 Innovative Growth Stocks That'll Make You Richer Through 2025 Motley Fool
Oct-04-21 11:54AM	Director Of Progyny Sold $930K In Stock Benzinga
Oct-01-21 01:27PM	Is Progyny (PGNY) A Smart Long-Term Buy? Insider Monkey
Sep-27-21 01:23PM	Progyny (NASDAQ:PGNY) shareholder returns have been solid, earning 122% in 1 year Simply Wall St.
Sep-15-21 03:42PM	IBD 50 Stocks To Watch: The Leading Name In This Nascent Market Nears Buy Point Investor's Business Daily
Sep-11-21 09:12AM	Billionaire Jeffrey Talpins Top 10 Stocks Picks Insider Monkey
Sep-10-21 05:18PM	Director Of Progyny Makes $964.31 Thousand Sale Benzinga
12:00PM	Progyny, Inc. to Present at the BofA Global Healthcare Conference GlobeNewswire
Sep-08-21 08:30PM	Chief Executive Officer Of Progyny Trades $2.90 Million In Company Stock Benzinga
Sep-04-21 06:43AM	Why This Ultra-High-Growth Healthcare Stock Is a Buy Motley Fool
Sep-02-21 01:19AM	Is Progyny (PGNY) A Good Stock To Buy Now? Insider Monkey
Aug-24-21 08:00AM	Castlight Health Expands Ecosystem with Four New Digital Health Partners PR Newswire
Aug-13-21 02:46PM	10 Best Stocks to Invest In According to Philip Timons Owls Nest Partners Insider Monkey
12:57PM	Is Progyny, Inc. (PGNY) A Smart Long-Term Buy? Insider Monkey
Aug-12-21 09:00AM	Progyny, Inc. Offers Paid Pregnancy Loss Leave to its Employees GlobeNewswire
Aug-06-21 12:00PM	Progyny, Inc. to Present at the BofA Securities SMID Cap 2H21 Ideas Conference GlobeNewswire -12.83%
Aug-05-21 07:25PM	Progyny (PGNY) Beats Q2 Earnings Estimates Zacks
04:05PM	Progyny, Inc. Announces Second Quarter 2021 Results GlobeNewswire
Jul-29-21 03:05PM	Progyny (PGNY) Reports Next Week: Wall Street Expects Earnings Growth Zacks
06:31AM	Are Institutions Heavily Invested In Progyny, Inc.'s (NASDAQ:PGNY) Shares? Simply Wall St.
Jul-22-21 03:30PM	Progyny, Inc. Announces Details for Its Second Quarter 2021 Results Report GlobeNewswire
12:00PM	Progyny (PGNY) Moves to Strong Buy: Rationale Behind the Upgrade Zacks
Jul-20-21 06:45PM	3 Small-Cap Healthcare Stocks Worth a Look Motley Fool
Jul-13-21 02:05PM	Hedge Funds Are Crazy About Progyny, Inc. (PGNY) Insider Monkey
06:02AM	Progyny (PGNY) Sees Hammer Chart Pattern: Time to Buy? Zacks
Jul-07-21 03:37PM	IBD 50 Stock To Watch Progyny Has Rallied 365%; Will It Rebound Or Build A Base? Investor's Business Daily
Jun-29-21 08:10AM	Dow Jones Futures: Covid Fears Shake Up Market Rally; Facebook Tops $1 Trillion; Tesla Rival Nio Flashes Buy Signal Investor's Business Daily
Jun-23-21 12:00PM	Here's Why Progyny (PGNY) is a Great Momentum Stock to Buy Zacks
Jun-19-21 06:51PM	These Are The 5 Best Stocks To Buy And Watch Now Investor's Business Daily
Jun-16-21 02:27PM	Dow Jones Falls As Fed Sees Rates Rising Sooner; Apple Dips; AMC Stock Plunges, Meme Names Fall Investor's Business Daily
Jun-14-21 05:20AM	Is Progyny, Inc.'s (NASDAQ:PGNY) Latest Stock Performance A Reflection Of Its Financial Health? Simply Wall St.
Jun-10-21 08:43AM	Progyny's (PGNY) Shares March Higher, Can It Continue? Zacks
Jun-04-21 11:00AM	Progyny, Inc. to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference GlobeNewswire
Jun-02-21 12:20PM	Earnings Estimates Moving Higher for Progyny (PGNY): Time to Buy? Zacks
Jun-01-21 07:33AM	Is It Too Late to Buy Progyny? TheStreet.com

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Payson Norman	Director	Nov 23	Sale	56.29	200	11,258	580,656	Nov 26 04:34 PM
Payson Norman	Director	Jun 23	Sale	28.76	6,618	190,319	444,502	Jun 24 04:18 PM
Payson Norman	Director	Jun 22	Sale	27.35	6,618	181,002	451,120	Jun 24 04:18 PM
Payson Norman	Director	Jun 09	Sale	29.21	6,618	193,320	457,738	Jun 10 04:20 PM
Payson Norman	Director	Jun 08	Sale	30.37	6,618	200,989	464,356	Jun 10 04:20 PM
Payson Norman	Director	May 26	Sale	33.91	6,618	224,416	470,974	May 31 08:02 AM
Payson Norman	Director	May 25	Sale	32.09	6,618	212,383	477,592	May 31 08:02 AM
Bealer Jennifer	EVP, GENERAL COUNSEL	May 17	Option Exercise	4.80	25,546	122,537	103,461	May 19 05:26 PM
Payson Norman	Director	May 12	Sale	33.28	6,618	220,252	484,210	May 13 04:42 PM
Payson Norman	Director	May 11	Sale	33.45	6,618	221,347	490,828	May 13 04:42 PM
Payson Norman	Director	Apr 21	Sale	43.21	8,330	359,950	497,446	Apr 22 04:12 PM
Payson Norman	Director	Apr 20	Sale	43.91	8,330	365,761	505,776	Apr 22 04:12 PM
Payson Norman	Director	Apr 08	Sale	45.41	8,330	378,251	514,106	Apr 11 06:47 PM
Payson Norman	Director	Apr 07	Sale	46.79	8,330	389,766	522,436	Apr 11 06:47 PM
Schlanger David J	EXECUTIVE CHAIRMAN	Apr 05	Option Exercise	0.91	50,000	45,500	134,000	Apr 07 04:21 PM
Schlanger David J	EXECUTIVE CHAIRMAN	Apr 05	Sale	48.30	50,000	2,415,150	84,000	Apr 07 04:21 PM
Schlanger David J	Executive Chairman	Apr 04	Option Exercise	0.91	50,000	45,500	134,000	Apr 05 04:17 PM
Schlanger David J	Executive Chairman	Apr 04	Sale	49.80	50,000	2,489,889	84,000	Apr 05 04:17 PM
Schlanger David J	Executive Chairman	Apr 01	Option Exercise	0.91	50,000	45,500	134,000	Apr 05 04:17 PM
Schlanger David J	Executive Chairman	Apr 01	Sale	51.82	50,000	2,590,824	84,000	Apr 05 04:17 PM
Payson Norman	Director	Mar 17	Sale	47.80	8,330	398,212	305,766	Mar 18 04:32 PM
Payson Norman	Director	Mar 16	Sale	44.99	8,330	374,760	314,096	Mar 18 04:32 PM
Payson Norman	Director	Mar 10	Sale	44.38	8,330	369,719	322,426	Mar 11 04:33 PM
Payson Norman	Director	Mar 09	Sale	45.50	8,510	387,243	330,756	Mar 11 04:33 PM
Anevski Peter	Chief Executive Officer	Mar 04	Sale	43.59	21,000	915,394	0	Mar 08 05:11 PM
Schlanger David J	Executive Chairman	Mar 03	Option Exercise	0.91	50,000	45,500	134,000	Mar 04 09:43 PM
Anevski Peter	Chief Executive Officer	Mar 03	Sale	43.67	21,000	917,040	21,000	Mar 04 09:33 PM
Payson Norman	Director	Mar 03	Sale	43.67	8,330	363,755	339,086	Mar 04 09:35 PM
Schlanger David J	Executive Chairman	Mar 03	Sale	43.67	50,000	2,183,500	84,000	Mar 04 09:43 PM
Schlanger David J	Executive Chairman	Mar 02	Option Exercise	0.91	50,000	45,500	134,000	Mar 04 09:43 PM
Schlanger David J	Executive Chairman	Mar 02	Sale	44.01	50,000	2,200,353	84,000	Mar 04 09:43 PM
Payson Norman	Director	Mar 02	Sale	44.00	8,330	366,532	347,416	Mar 04 09:35 PM
Anevski Peter	Chief Executive Officer	Mar 02	Sale	44.02	21,000	924,388	42,000	Mar 04 09:33 PM
Schlanger David J	Executive Chairman	Mar 01	Option Exercise	0.91	50,000	45,500	134,000	Mar 02 05:43 PM
Schlanger David J	Executive Chairman	Mar 01	Sale	42.49	50,000	2,124,409	84,000	Mar 02 05:43 PM
Anevski Peter	Chief Executive Officer	Mar 01	Sale	42.50	21,000	892,463	23,135	Mar 02 06:49 PM
Schlanger David J	Executive Chairman	Feb 28	Option Exercise	0.91	139,776	127,196	223,776	Mar 02 05:43 PM
Schlanger David J	Executive Chairman	Feb 28	Sale	39.13	139,776	5,469,435	84,000	Mar 02 05:43 PM
Anevski Peter	Chief Executive Officer	Feb 28	Sale	39.09	125,931	4,922,643	44,135	Mar 02 06:49 PM
Payson Norman	Director	Feb 24	Sale	35.20	8,330	293,212	355,746	Feb 25 04:31 PM
Payson Norman	Director	Feb 23	Sale	35.30	8,330	294,038	364,076	Feb 25 04:31 PM
Payson Norman	Director	Feb 17	Sale	39.40	8,330	328,200	372,406	Feb 18 04:46 PM
Schlanger David J	Executive Chairman	Feb 16	Option Exercise	0.91	1,600	1,456	85,600	Feb 17 04:36 PM
Schlanger David J	Executive Chairman	Feb 16	Sale	41.00	1,600	65,600	84,000	Feb 17 04:36 PM
Anevski Peter	Chief Executive Officer	Feb 16	Sale	41.01	2,500	102,525	170,066	Feb 17 09:34 PM
Payson Norman	Director	Feb 16	Sale	40.49	8,330	337,320	380,736	Feb 18 04:46 PM
Schlanger David J	Executive Chairman	Feb 15	Option Exercise	0.91	7,624	6,938	91,624	Feb 17 04:36 PM
Schlanger David J	Executive Chairman	Feb 15	Sale	41.36	7,624	315,329	84,000	Feb 17 04:36 PM
Anevski Peter	Chief Executive Officer	Feb 15	Sale	41.39	17,569	727,181	172,566	Feb 17 09:34 PM
Schlanger David J	Executive Chairman	Feb 11	Option Exercise	0.91	1,000	910	85,000	Feb 15 09:09 PM
Anevski Peter	Chief Executive Officer	Feb 11	Sale	42.00	600	25,200	654,462	Feb 15 08:58 PM
Schlanger David J	Executive Chairman	Feb 11	Sale	42.00	1,000	42,000	84,000	Feb 15 09:09 PM
Payson Norman	Director	Feb 10	Sale	40.79	8,330	339,743	389,066	Feb 11 04:31 PM
Payson Norman	Director	Feb 09	Sale	40.35	8,330	336,110	397,396	Feb 11 04:31 PM
Payson Norman	Director	Feb 03	Sale	37.63	8,330	313,419	405,726	Feb 04 05:00 PM
Payson Norman	Director	Feb 02	Sale	39.29	8,330	327,324	414,056	Feb 04 05:00 PM
Payson Norman	Director	Jan 27	Sale	37.34	8,330	311,038	422,386	Jan 28 04:16 PM
Payson Norman	Director	Jan 26	Sale	38.46	8,330	320,396	430,716	Jan 28 04:16 PM
Payson Norman	Director	Jan 20	Sale	39.36	8,330	327,881	439,046	Jan 21 05:00 PM
Payson Norman	Director	Jan 19	Sale	39.20	8,330	326,556	447,376	Jan 21 05:00 PM
Payson Norman	Director	Jan 13	Sale	44.44	8,330	370,152	455,706	Jan 14 05:42 PM
Payson Norman	Director	Jan 12	Sale	46.52	8,330	387,510	464,036	Jan 14 05:42 PM
Payson Norman	Director	Jan 06	Sale	46.02	8,330	383,349	472,366	Jan 07 05:52 PM
Payson Norman	Director	Jan 05	Sale	46.99	8,330	391,396	480,696	Jan 07 05:52 PM
Schlanger David J	Executive Chairman	Jan 04	Option Exercise	0.91	704	641	84,704	Jan 05 06:39 PM
Anevski Peter	Chief Executive Officer	Jan 04	Sale	51.06	400	20,424	62,600	Jan 05 06:19 PM
Schlanger David J	Executive Chairman	Jan 04	Sale	51.27	704	36,094	84,000	Jan 05 06:39 PM
Schlanger David J	Executive Chairman	Jan 03	Option Exercise	0.91	50,000	45,500	134,000	Jan 05 06:39 PM
Schlanger David J	Executive Chairman	Jan 03	Sale	51.17	50,000	2,558,500	84,000	Jan 05 06:39 PM
Anevski Peter	Chief Executive Officer	Jan 03	Sale	51.17	21,000	1,074,570	63,000	Jan 05 06:19 PM
Payson Norman	Director	Dec 30	Sale	51.82	8,330	431,697	489,026	Jan 03 06:13 PM
Schlanger David J	Executive Chairman	Dec 29	Option Exercise	0.91	73,095	66,516	73,095	Jan 03 04:45 PM
Payson Norman	Director	Dec 29	Sale	51.91	8,330	432,391	497,356	Jan 03 06:13 PM
Schlanger David J	Executive Chairman	Dec 29	Sale	52.18	73,095	3,814,097	0	Jan 03 04:45 PM
Schlanger David J	Chief Executive Officer	Dec 28	Option Exercise	0.81	66,005	53,464	66,005	Dec 29 04:45 PM
Schlanger David J	Chief Executive Officer	Dec 28	Sale	52.40	66,005	3,458,662	0	Dec 29 04:45 PM
Schlanger David J	Chief Executive Officer	Dec 27	Option Exercise	0.91	10,900	9,919	10,900	Dec 29 04:45 PM
Schlanger David J	Chief Executive Officer	Dec 27	Sale	52.80	10,900	575,520	0	Dec 29 04:45 PM
Payson Norman	Director	Dec 23	Sale	51.53	8,330	429,258	505,686	Dec 27 04:36 PM
Payson Norman	Director	Dec 22	Sale	50.62	8,330	421,696	514,016	Dec 27 04:36 PM
Payson Norman	Director	Dec 16	Sale	47.78	8,330	397,979	522,346	Dec 17 04:43 PM
Payson Norman	Director	Dec 15	Sale	47.60	8,330	396,488	530,676	Dec 17 04:43 PM
Payson Norman	Director	Dec 09	Sale	49.81	8,330	414,956	539,006	Dec 10 06:01 PM
Payson Norman	Director	Dec 08	Sale	50.65	8,330	421,886	547,336	Dec 10 06:01 PM
Payson Norman	Director	Dec 02	Sale	48.79	8,330	406,441	555,666	Dec 03 05:28 PM
Payson Norman	Director	Dec 01	Option Exercise	1.45	225,000	326,250	233,652	Dec 03 05:28 PM
Payson Norman	Director	Dec 01	Sale	50.13	8,330	417,621	563,996	Dec 03 05:28 PM
Payson Norman	Director	Nov 24	Sale	53.71	8,330	447,388	572,326	Nov 26 04:34 PM
Payson Norman	Director	Nov 23	Sale	54.26	8,130	441,147	580,856	Nov 26 04:34 PM
Bealer Jennifer	EVP, GENERAL COUNSEL	Nov 18	Option Exercise	0.91	6,876	6,257	76,292	Nov 22 05:38 PM
Payson Norman	Director	Nov 18	Sale	58.97	8,330	491,232	588,986	Nov 19 04:15 PM
Payson Norman	Director	Nov 17	Sale	63.36	8,330	527,776	597,316	Nov 19 04:15 PM
Payson Norman	Director	Nov 11	Sale	61.29	8,330	510,585	605,646	Nov 12 05:38 PM
Payson Norman	Director	Nov 10	Sale	63.18	8,330	526,308	613,976	Nov 12 05:38 PM
Livingston Mark S.	Chief Financial Officer	Nov 08	Option Exercise	3.95	34,375	135,919	124,273	Nov 10 04:56 PM
Scott Cheryl	Director	Nov 08	Sale	66.30	2,000	132,600	5,210	Nov 10 04:37 PM
Livingston Mark S.	Chief Financial Officer	Nov 08	Sale	65.61	15,858	1,040,507	108,415	Nov 10 04:56 PM
Bealer Jennifer	EVP, General Counsel	Nov 08	Sale	65.79	22,125	1,455,600	69,416	Nov 09 08:57 PM
Bealer Jennifer	EVP, General Counsel	Nov 05	Sale	65.39	10,090	659,752	61,541	Nov 09 08:57 PM
Payson Norman	Director	Nov 04	Sale	61.12	8,330	509,142	622,306	Nov 05 04:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience